2021 Advances

The pandemic has forced us to revolutionise our approach

2021 Advances
Rudy Nuijts
Rudy Nuijts
Published: Monday, February 1, 2021
This year marks the 25th anniversary of the first issue of EuroTimes, published in January 1996. Enormous advances have been made in that time in the armamentarium we have available to us to diagnose and treat our patients. And yet 2021 finds us paralysed by a pandemic that has revolutionised our relationships with our patients and our colleagues. As Dr Malvina Eydelman MD, officer of Health Technology at the FDA, pointed out in her 2020 Peter Barry Memorial Lecture in Dublin this November, the COVID-19 pandemic has forced doctors to rapidly adopt new ways to take care of their patients. I recommend that you read the report of her presentation in this issue of EuroTimes as it succinctly spells out some of the key challenges we will face in the future. As ophthalmologists, we will embrace new technologies, artificial intelligence, telemedicine and digital health applications to improve communications between both patients and doctors. Most of all, I look forward to the time when we can meet friends and colleagues outside of our virtual bubble. The success of our first virtual meeting, the 38th Congress of the ESCRS, has shown us that it is possible to interact remotely with a first-class scientific programme. We will convene the 39th Congress of the ESCRS from 27-30 August in the RAI Amsterdam, the Netherlands. As multiple vaccines are rolled out across Europe, our hope is that this will be a hybrid Congress with delegates and industry partners convening onsite in the RAI and at the same time communicating virtually with our colleagues across the world who are unable to travel. As events unfold over the next few months, we will keep you updated on our plans. Very best wishes to you for a New Year where we will be free to meet face to face, in the meantime, I urge you, your families and your loved ones to stay safe and stay well.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...